Catalonia's biomedical raised 102 million euros in investment in 2017

Biomedical companies in the Spanish Catalan region attracted 102 million euros ($120 million) in investment in 2017, with 3.4 million euros per operation, on average.

This will allow them to push forward in the development of drugs and innovative medical technology, as reflected in the Study oninvestment in the Biomedical industry in Catalonia: Achievements and future challenges presented by CataloniaBio & HealthTech and EY in Barcelona. The event attracted more than 60 entrepreneurs, investors and professionals from the sector.

Venture capital continues to be the main source of funding for companies that develop products (33%), while service firms tend to opt for private debt (74%). Most investors are from Catalonia (76%), although foreign capital is increasing (from 12% in 2016 to 16% in 2017).